neoplasm
|
|
• at 10 months of age, the % of mice with palpable mammary tumors is significantly lower than that in age-matched mice carrying the transgene on a wild-type background
|
|
|
• at 15 months of age, mice show a significant decrease in mammary tumor volume relative to age-matched mice carrying the transgene on a wild-type background
|
|
|
• mice develop the first palpable mammary tumor at ~500 days, i.e. significantly later than mice carrying the transgene on a wild-type background
|
endocrine/exocrine glands
|
|
• at 10 months of age, the % of mice with palpable mammary tumors is significantly lower than that in age-matched mice carrying the transgene on a wild-type background
|
integument
|
|
• at 10 months of age, the % of mice with palpable mammary tumors is significantly lower than that in age-matched mice carrying the transgene on a wild-type background
|


Analysis Tools